Posts

, , , , , ,

Diabetes Drug Invokana Linked to Cardiovascular Risks and Diabetic Ketoacidosis

Invokana (canagliflozin) was approved by the FDA in March 2013 to treat patients who suffer from Type 2 diabetes. It is prescribed to improve glycemic control and to lower blood sugar in adults with Type 2 diabetes mellitus. Diabetes causes…
, , ,

Benicar Use Can Lead to Severe Gastrointestinal Issues

In 2013, the FDA announced that the drug Benicar may cause severe gastrointestinal side effects. Benicar has been marketed as Benicar, Benicar HCT, Azor, Tribenzor, and in the generic form Olmesartan Medoxomil. Problems associated with Benicar…
, ,

Onglyza Linked to Increased Risk of Heart Failure

Onglyza has been linked to an increased risk of heart failure and even death, and Lawsuits are now being filed against the drug’s manufacturer (AstraZeneca) on behalf of those injured. If you or a loved one has taken the drug Onglyza and…
, ,

Use of Taxotere Can Lead To Permanent Hair Loss

Taxotere is a chemotherapy drug that is primarily used to treat breast cancer. The drug prevents breast cancer cell from growing and dividing. It is administered to the patient intravenously by a medical professional in a clinic or hospital. Taxotere…
, , , , ,

What You Need To Know About Stelara Lawsuits

Recent reports suggest that there is a much greater risk of cancer associated with Stelara than with the use other comparable psoriasis medications. Here is what you need to know about Stelara and how you can go about seeking compensation for…